MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?

Familial hypercholesterolemia (FH) is the most common inherited form of dyslipidemia and a major cause of premature cardiovascular disease. Management of FH mainly relies on the efficiency of treatments that reduce plasma low-density lipoprotein (LDL) cholesterol (LDL-C) concentrations. MicroRNAs (m...

Descripción completa

Detalles Bibliográficos
Autores principales: Momtazi, Amir Abbas, Banach, Maciej, Pirro, Matteo, Stein, Evan A., Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874276/
https://www.ncbi.nlm.nih.gov/pubmed/28534160
http://dx.doi.org/10.1007/s12016-017-8611-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874276/
https://www.ncbi.nlm.nih.gov/pubmed/28534160
http://dx.doi.org/10.1007/s12016-017-8611-x

Ejemplares similares